FIELD: chemistry.
SUBSTANCE: invention relates to organic chemistry and specifically to derivatives of S-5-arylidene-2-(arylthio)-3,5-dihydro-4H-imidazol-4-one of formulas 1 or 2, where R1 is a substitute selected from a hydrogen atom, a halogen atom, a methoxy group, a cyano group; R2 is a substituent selected from a hydrogen atom, a halogen atom; R3 a substitute selected from a hydrogen atom, a halogen atom, a methoxy group; R4 a substitute selected from a hydrogen atom, a halogen atom, a methoxy group; R5 - phenyl substituted with 1 substitute selected from halogen atom, lower alkoxy group. Invention also relates to a method of producing a compound of formula 1 or 2, a pharmaceutical composition and a medicinal agent based on a compound of formula 1 or 2.
EFFECT: technical result is obtaining novel heterocyclic compounds useful for preventing and treating oncological disease associated with androgen receptor activity.
15 cl, 2 dwg, 1 tbl, 25 ex
Title | Year | Author | Number |
---|---|---|---|
2-SELENOXO-TETRAHYDRO-4N-IMIDAZOL-4-ONE DERIVATIVE, METHOD FOR PRODUCTION AND USE THEREOF | 2019 |
|
RU2730550C1 |
METHOD FOR SYNTHESIS OF 4-(1H-INDOL-3-YL)-BUT-3-EN-2-ONE DERIVATIVES | 2009 |
|
RU2409564C1 |
LIGAND FOR OBTAINING A COMPLEX OF A TRANSITION METAL, A METHOD FOR ITS PRODUCTION AND A METHOD OF OBTAINING A COMPLEX OF A TRANSITION METAL USING A LIGAND | 2015 |
|
RU2616628C2 |
METHOD FOR OBTAINING DISPYROINDOLINONES BASED ON 5-INDOLIDENE-2-THIOHIDANTOINES | 2020 |
|
RU2756463C1 |
IMIDAZOLONE DERIVATIVES, METHOD FOR PREPARING, AND BIOLOGICAL USE | 2008 |
|
RU2491283C2 |
TRIPHENYLAMINE-BASED DONOR-ACCEPTOR OLIGOMERS WITH PHENYL DICYANOVINYL SUBSTITUENTS AND METHOD OF PRODUCING SAME | 2015 |
|
RU2667362C2 |
COMPOSITIONS FOR PULMONARY FIBROSIS TREATMENT | 2017 |
|
RU2747801C2 |
THIOHYDANTOIN DERIVATIVES USEFUL AS ANDROGEN RECEPTOR ANTAGONISTS | 2012 |
|
RU2598854C2 |
FLUORESCENTLY-LABELED DEOXYURIDINE TRIPHOSPHATES | 2016 |
|
RU2637310C1 |
1-(2-ISOPROPOXYETHYL)-2-THIOXO-1,2,3,5-TETRAHYDRO-PYRROLO[3,2-d]PYRIMIDIN-4-ONE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | 2005 |
|
RU2409578C2 |
Authors
Dates
2019-12-05—Published
2017-12-05—Filed